相关实验视频
Updated: Jan 29, 2026

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
6.5K
晶甲基氨酸心肌病:一个快速发展的景观
Lawrence Zeldin1, Yevgeniy Brailovsky1, Mathew S Maurer1
1Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA;
Annual review of medicine
|January 27, 2026
概括
作为心力衰竭的原因,Transthyretin amyloid心肌病变 (ATTR-CM) 越来越多地被诊断为非侵入性. 新的治疗方法和诊断方法正在改变以前致命的预后.
科学领域:
- 心脏病学 心脏病学
- 心肌病是一种心肌病.
- 氨基粉症是什么 氨基粉症
背景情况:
- 晶胺氨基酸心肌病变 (ATTR-CM) 是心力衰竭的一个显著的,未被确诊的原因.
- 从历史上看,ATTR-CM的预后很差,往往是晚诊断的.
- 最近的进展正在改变诊断和治疗的格局.
研究的目的:
- 审查ATTR-CM的流行病学,病理生理学,诊断和治疗.
- 要突出最近的发展转变ATTR-CM管理.
- 探索该领域新出现的问题.
主要方法:
- 关于ATTR-CM的当前文献的综述.
- 强调非侵入性诊断方式.
- 讨论新的治疗策略和标准的心力衰竭管理.
主要成果:
- 非侵入性成像可以更早地诊断ATTR-CM.
- 向积极查和确认的转变正在改善检测率.
- 新疗法的开发和现有治疗方法的精细使用提供了更好的结果.
结论:
- ATTR-CM管理已经转向早期诊断和有效治疗.
- 非侵入性诊断和新疗法正在改善患者的治疗结果.
- 目前正在进行的研究解决了ATTR-CM护理的剩余挑战和未来方向.
相关概念视频
Amyloid Fibrils
11.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Amyloid Fibrils
6.4K
6.4K
Cardiomyopathy II: Dilated Cardiomyopathy
549
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
549
Cardiomyopathy III: Hypertrophic Cardiomyopathy
467
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
467
Cardiomyopathy IV: Restrictive Cardiomyopathy
519
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
519
Cardiomyopathy V: Interprofessional Care
396
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
396

